drugset / Trial / NCT02266940
Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets
RandomizedCrossoverOpen-labelBasic science
Summary
This is an open label, randomised, 3 treatment, 3 period crossover study. This study is designed to assess the relative bioavailability of DS 1971a from a tablet formulation and a reconstituted oral suspension and the effect of a high fat meal on the relative bioavailability of DS 1971a from the tablet formulation.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS-1971 | Small molecule | 200 mg | Oral |
Indications
No indication recorded.